Calliditas shares rise as phase 3 endpoints met in kidney disease trial
Swedish company Calliditas Therapeutics AB has announced positive topline results from the global, randomized, double-blind,…
March 14, 2023 - 4 minutes
Swedish company Calliditas Therapeutics AB has announced positive topline results from the global, randomized, double-blind,…
Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like…
The first and only approved treatment for primary immunoglobin A (IgA) nephropathy, a rare, progressive…
Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market…
Women are underrepresented in biotech leadership roles in Europe, but things are slowly improving. We…